
Herbert Loong/X
Jun 10, 2025, 03:30
Herbert Loong: Discussing the Role of Selective RET Inhibitors in NSCLC
Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared a post on X:
“Thanks Herdee Luna, Roselle De Guzman and other thoracic oncology colleagues from Philippines for your wonderful invite and hospitality as we discussed role of selective RETinhibitors, importance of moleculartesting in nsclc and beyond.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 10, 2025, 03:30
Jun 10, 2025, 02:43
Jun 9, 2025, 19:54
Jun 9, 2025, 19:26